6 August 2015
DETAILS
Novozymes Interim report for the first half of 2015,
* Net profit grew by 8%, and
* free cash flow before acquisitions
came in at DKK 1,616 million
Peder Holk Nielsen,
President and CEO of Novozymes
“First-half earnings have been very satisfactory,
but we need to increase growth.
Some customers in Household Care and Bioenergy
are challenged by volatile markets, creating
short-term headwinds for us until we have fully adapted.
Good developments in other areas such as
Agriculture & Feed and Food & Beverages
balance things out but don’t make up for the headwinds.
We therefore reduce our sales growth expectations
for the full year. We maintain our full-year profit outlook,
as we see improved productivity and
operational efficiencies leading to a higher EBIT margin.”
WWW.CHEMWINFO.COM BY KHUN PHICHAI
